Skip to main content

Diagnosis of Acute Cardiogenic Pulmonary Edema (ACPE) with Point-of-Care Ultrasound

Point-of-Care Ultrasonography (POCUS) is a valuable tool in the diagnostic armamentarium of the emergency physician. We have been successfully using it to the place lines, diagnose AAAs and assess the cardiac function of our dyspnea patients for awhile now. But what about the lungs? Typically air is thought of as the enemy of ultrasound, but can we successfully use it to diagnose acute respiratory conditions despite this? In this Grand Rounds review, Dr. Elizabeth Lalande goes through the use of POCUS in the diagnosis of Acute Cardiogenic Pulmonary Edema in the undifferentiated, dyspneic patient. 

The objectives are as follows:
1. Definitions in lung ultrasound (US)
2. The role of POCUS in diagnosing acute cardiogenic pulmonary edema

Definitions in Lung Ultrasound

B-line: A discrete laser-like, vertical, hyperechoic reverberation artifact. It arises from the pleural line, extends to the bottom of the screen without fading, and moves synchronously with lung sliding.

Physics of the B-line: Occurs when there is a change in acoustic impedance between an object and its surroundings. The reflection of the beam creates a phenomenon called "resonance." The US beam gets trapped within the system and results in an endless "to-and-fro" mechanism. This results in an endless beam as seen on the screen. 

Positive zone for B-lines: A positive zone is determined when there are at least 3 B-lines in one intercostal space that can be seen at any moment during a respiratory cycle.

Multiple B-lines in one intercostal space. From Lichtenstein DA et al. The Comet-tail artifact: An Ultrasound Sign of Alevolar-Interstitial Syndrome. Am J Respir Crit Care Med 1997; 156: 1640-1646
Alveolo-interstitial syndrome (AIS): This syndrome is defined by a B-profile, as described by Lichtenstein DA and Mezière GA in their 2008 study: "Relevance of Lung Ultrasound in the Diagnosis of Acute Respiratory Failure, The BLUE protocol" published in Chest (2). The B-profile will have two separate, positive zones for B-lines, as previously defined, bilaterally.
Lung US profiles. From Lichtenstein DA and Mezière GA, Relevance of Lung Ultrasound in the Diagnosis of Acute Respiratory Failure, The BLUE protocol. (2)

Role of POCUS in Diagnosing ACPE
The sensitivity of POCUS for AIS is around 97% with a specificity of 95%.  Considering that previous studies looking at the test characteristics of CXR, which is used on a daily basis for this purpose, showed a sensitivity ranging from 50 to 70% for AIS as interpreted by a Cardiologist, these figures are quite impressive.
The differential diagnosis for AIS, however, includes a variety of lung conditions not just ACPE but also acute respiratory distress syndrome, interstitial pneumonia and diffuse parenchymal lung disease, as described by the International evidence-based recommendations for Point-of-Care lung ultrasound, published in 2012 (3). So the clinical context of the scan is as important as the scan itself.
In terms of technique to elicit the B-profile, the best method was described by Volpicelli et al. in 2006. They described an 8 zones technique, 4 zones on each side of the thorax, as shown below:

The 8 zones technique, described by Volpicelli in 2006 (4)
The next question after a scanning protocol is determined is, can we accurately use POCUS to diagnose ACPE in the ED?

Fortunately, there are two major literature sources that can answer that for us:

These patients all presented with acute dyspnea and a suspicion of ACPE, which is pretty similar to our population in the ED. There was no restriction on the protocol, machine or operator performing the scan used as long as they used B-lines to make the diagnosis and the physicians performing the scan was a non-radiologist at the bedside. 

The primary outcome was the clinical diagnosis of ACPE using POCUS with B-lines and the reference standard was final diagnosis at clinical follow-up. The pooled sensitivity was 94% and specificity was 93%. They did another analysis without 3 of the studies that could alter the estimates and found similar results. This study showed us that lung US has great test characteristics to diagnosis ACPE.

This review looked at the operating test characteristics of the different modalities used by emergency physicians (EPs) for the diagnosis of ACPE among patients presenting to the ED with dyspnea. They included the performance of lung US in the diagnostic work-up. Studies eligible focused on the diagnosis of acute heart failure in the ED population. 

Their search for lung US studies was not limited to a specific protocol but they narrowed their inclusion of studies investigating lung US and echocardiography to those that had EPs both performing and interpreting the lung US

Eight studies were included in the final analysis for lung US. Their results: a pooled sensitivity of 85% and specificity of 92% with a +LR of 7.4 and a negative one of 0.16 for lung US. Once again, this study has demonstrated that lung US is a great diagnostic tool for us when looking for ACPE in the acute, undifferentiated dysnpneic patient. 

How about integrating cardiac views as well? 
ACPE comes from a sick heart. It is certainly useful to visualize the left ventricular systolic function to assess if it goes in hand with the diagnosis of ACPE. If the echo views show a depressed systolic left ventricular function, then it really helps confirm the diagnosis. 

1. Lung US is a great tool to diagnose ACPE, with excellent test characteristics.
2. An eight zone protocol can be used at the bedside to look for the B-profile in your patients with undifferentiated dyspnea. Remember a B-profile consists of at least 3 B-lines in one intercostal space. 
3. Don’t forget to look at the heart as well, to increase your post-test probability of finding the right diagnosis for your patient!
---- Dr. Elizabeth Lalande, MD, FRCPC is an Emergency Medicine POCUS Fellow at the University of Ottawa. She also works as a staff physician at The Ottawa Hospital. 
Edited and Formatted by Dr. R Suttie, PGY2, Emergency Medicine. 
1. Lichtenstein DA and coll., The Comet-tail Artifact: An Ultrasound Sign of Alveolar-Interstitial Syndrome. Am J Respir Crit Care Med 1997;156:1640–1646.
2. Lichtenstein DA and Mezière GA, Relevance of Lung Ultrasound in the Diagnosis of Acute Respiratory Failure* The BLUE Protocol. CHEST 2008;134:117–125.
3. Volpicelli G and coll., International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med 2012;38:577–591.
4. Volpicelli G and coll., Bedside lung ultrasound in the assessment of alveolar-interstitial syndrome. AJEM 2006; 24(6):689-96.
5. Al Deeb M and coll., Point-of-care ultrasonography for the Diagnosis of Acute Cariogenic Pulmonary Edema in Patients Presenting with Acute Dyspnea: A systematic Review and Meta-Analysis. Acad Emer Med 2014;21:844–852.
6. Martindale JL and coll., Diagnosing Acute Heart Failure in the Emergency Department: A Systematic Review and Meta-analysis. Acad Emer Med 2016;23:223–242.


Popular posts from this blog

Tips for Success in your Emergency Medicine Rotation

Our wonderful medical students are preparing to start their first clinical rotations. With this in mind here are some of the top tips for success in your EM rotation
1)Be On Time – show up to your shifts on time, better yet 5 minutes early.That first impression is immensely important.
2)Introduce yourself to the team - “Hi my name is John Doe, I am the medical student on shift today” introduce yourself to the attending, residents, nurses, etc.You will be called on a lot more to help when there is something interesting going on if they know your name.
3)Be goal-oriented – have a goal for each shift, whether it’s a procedure or a type of presentation to see.
4)Don’t just stand there, do something – whenever there is a trauma or code, come to the bedside.Get gowned up for traumas and pay attention.Help with things that are within your scope of practice: chest compressions, moving patient, cardioversion
5)Don’t just stand there, do nothing – there are times in medicine when the best thing to d…

2014 Canadian Guidelines for AF Management: Part 1: Introduction and CCS “CHADS-65” Algorithm

by Ian Stiell MD @EMO_Daddy

In this and subsequent postings we will discuss the latest recommendations for ED management of atrial fibrillation (AF) as presented in the newly published 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. The Guidelines PDF can be downloaded from the CCS website at 2014 Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
The 2014 Focused Update uses the GRADE system of evidence evaluation as was the case in the comprehensive 2010 AF Guidelines and the 2012 Update. The CCS AF Guidelines Panel is comprised of Canadian cardiologists plus physicians from internal medicine, family medicine, neurology, and emergency medicine. This 2014 Update provides evidence review and recommendations for 8 aspects of AF care, including ED Management (written by myself and Dr. Laurent Macle of the Montreal Heart Institute). The 2014 Update focuses on advances in oral anticoagulant (O…

You CAN reverse that! Reversal of NOAC's and more..

We have seen a large surge of the utilization of New Oral Anticoagulants (NOAC's) in the past few years, as such, it has been a novel challenge when these patients present to the Emergency Department (ED) with life threatening bleeding. Dr. Michael Ho looks to discuss treatment options, and future options in these patients. 
NOACs vs WarfarinDabigatran, Rivaroxaban and Apixaban have seen a dramatic increase in use since their approval in Canada. Dabigatran is a direct thrombin (Factor II) inhibitor, while the latter two are direct Xa inhibitors. These drugs are collectively referred to as novel oral anticoagulants (NOACs). They have also been called direct, or target-specific oral anticoagulants (DOACs or TSOACs) [1]. 
The NOACs have many practical advantages over warfarin: Rapid onset of actionShorter half-lifeLess food and drug interferencePredictable pharmacokineticsEase of use and no requirement for monitoringThe downsides to NOACs are the higher cost to the patient, the inabilit…